A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals

Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
12/2002
12/31/2002	US6500668 Culture medium for avian embryonic cells
12/31/2002	US6500428 Antibodies to a lymphocyte surface receptor that binds CAML and methods of use thereof
12/31/2002	US6500422 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3)
12/27/2002	WO2002103472A2 Pet food kiosk
12/27/2002	WO2002103350A1 Methods for cloning mammals using remodeling factors
12/27/2002	WO2002102998A1 Animal with gene hypoexpression
12/27/2002	WO2002102968A1 Apparatus for and methods of preparing sperm
12/27/2002	WO2002102967A1 Apparatus for and methods of in vitro fertilization
12/27/2002	WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002	WO2002102830A1 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
12/27/2002	WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002	WO2002102271A2 Method and apparatus for customizing a multiple component pet food
12/27/2002	WO2002102257A1 Apparatus for and methods of preparing sperm
12/27/2002	WO2002102172A1 Methods and apparatus for customizing pet food
12/27/2002	WO2002102144A1 Cell deah-inducible model nonhuman animal
12/27/2002	WO2002102143A1 Transgenic animal transformed using green fluorescent protein gene
12/27/2002	WO2002074072A3 Method for determining the therapeutic efficacy of a medicament against parkinson's disease and/or parkinson syndrome using an fri/fri mouse as a model
12/27/2002	WO2002029075A8 Multiple inducible gene regulation system
12/27/2002	WO2002012279A3 Schizophrenia related gene and protein
12/27/2002	WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
12/27/2002	CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002	CA2450652A1 Methods for cloning mammals using remodeling factors
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/26/2002	US20020199213 Transgenic transchromosomal rodents for making human antibodies
12/26/2002	US20020199212 Non-human animal exhibiting bone metastasis of tumor cells and method of screening for bone metastasis inhibitors
12/26/2002	US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002	US20020197676 Novel chromophores/fluorophores and methods for using the same
12/26/2002	US20020197268 Allergen-containing milk for allergy treatment
12/26/2002	US20020197237 Adeno-associated virus vectors
12/25/2002	CN1387576A Sequence-specific DNA recombination in ekaryotic cells
12/25/2002	CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity
12/25/2002	CN1387539A Human monoclonal antibodies to prostate specific membrane antigen
12/25/2002	CN1387444A Method of treatment using anti-ErbB antibody-maytansinoid conjugates
12/25/2002	CN1387399A Methods of producing target molecule in transgenic animal and purification of target molecule
12/24/2002	US6498285 Methods for producing transgenic pigs by microinjecting a blastomere
12/24/2002	US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof
12/19/2002	WO2002101385A1 In vivo bioreactors
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101017A2 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100998A2 Method for generating diversity
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100168A1 A method for constructing a cloned mammalian embryo
12/19/2002	WO2002081677A3 Improved gene expression
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020194638 Vector for genetically modifying non-human animals
12/19/2002	US20020194635 Transgenic bovine for use as animal model in the treatment of viral diseases
12/19/2002	US20020194634 Insect control system
12/19/2002	US20020194632 Transgenic knockouts of BACE-1
12/19/2002	US20020194631 Method of treating psoriasis using anti-interleukin 12 antibody
12/19/2002	US20020194629 Treatment of Staphylococcus infections
12/19/2002	US20020194626 Knockout animals
12/19/2002	US20020194625 Transgenic animals expressing heparanase and its uses
12/19/2002	US20020194624 Methods for screening and identifying host pathogen defense genes
12/19/2002	US20020193426 Contains a xanthene dye which is applied to the surface of or admixed with a nutritionally acceptable carrier to enhance the worm's detection by visual color receptor of a fish
12/19/2002	US20020193350 Contacting a sample containing sperm with a solution comprising a polysaccharide containing arabinose, galactose and/or hexuronic acid (PCAGH) to form a mixture, wherein the PCAGH is not arabinogalactan; separating sperm from the sample
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein
12/19/2002	US20020192815 Active retinoic acid-free culture medium for avian totipotent embryonic cells
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192160 Novel human tumor suppressor gene
12/19/2002	CA2450720A1 In vivo bioreactors
12/19/2002	CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449279A1 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/18/2002	EP1266015A2 Ecdysone receptor-based inducible gene expression system
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002	EP1265998A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics
12/18/2002	EP1265990A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
12/18/2002	EP1265984A2 In ovo activation of an avian egg in the shell
12/18/2002	EP1265926A1 Melanin concentrating hormone receptor chimeric and fusion proteins
12/18/2002	EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1265922A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control
12/18/2002	EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same
12/18/2002	EP1265918A1 Human immune response proteins
12/18/2002	EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/18/2002	EP1265480A1 Chimeric animal model susceptible to human hepatitis c virus infection
12/18/2002	EP1265479A1 Methods for gamete production in birds
12/18/2002	EP0946721B1 Human growth gene and short stature gene region
12/18/2002	EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/18/2002	CN1385064A Method for producing fodder by intensive stalk cultivating locust
12/18/2002	CN1385063A Method for breeding black rabbit
12/18/2002	CA2350868A1 Artificial diet and method using an artificial diet, for mass rearing of insects
12/17/2002	US6495736 Compositions and methods for increasing bone mineralization
12/17/2002	US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species
12/17/2002	US6495526 Inhibitors of cell-cycle progression and uses related thereto
12/17/2002	US6495364 Mx-1 conditionally immortalized cells

1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 341